Literature DB >> 9605918

Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation.

J M Swain1, C S Grant, R T Schlinkert, G B Thompson, J A vanHeerden, R V Lloyd, W F Young.   

Abstract

OBJECTIVES: To investigate the clinical presentation, laboratory findings, and pathologic characteristics of patients with corticotropin (ACTH)-independent macronodular adrenal hyperplasia.
DESIGN: Retrospective review.
SETTING: Academic medical center. PATIENTS: All patients with bilateral adrenocortical nodules associated with ACTH-independent hypercortisolism without clinicopathologic features of primary pigmented nodular adrenocortical disease with atrophic internodular adrenal cortex. MAIN OUTCOME MEASURES: Compare and contrast our findings with those previously reported; assess response to adrenalectomy.
RESULTS: Nine patients met the criteria for corticotropin-independent macronodular adrenal hyperplasia. All patients had biochemical evidence of Cushing syndrome, although repetitive testing was frequently required. As a result, the diagnosis was delayed from 1 to 20 years. In all patients, both the low- and high-dose dexamethasone suppression tests failed to suppress cortisol secretion. No patient had elevated ACTH levels, and following curative bilateral adrenalectomy, no patient subsequently developed Nelson syndrome, with follow-up ranging from 1 to 8.5 years. Unique histologic features were identified in all cases.
CONCLUSION: Amalgamating this series with other clinical reports plus basic research information, corticotropin-independent macronodular adrenal hyperplasia must be considered a separate and legitimate cause of Cushing syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605918     DOI: 10.1001/archsurg.133.5.541

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  18 in total

1.  A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure.

Authors:  D Suri; M Alonso; R E Weiss
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

2.  The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH).

Authors:  Maurizio Iacobone; Nora Albiger; Carla Scaroni; Franco Mantero; Ambrogio Fassina; Giovanni Viel; Mauro Frego; Gennaro Favia
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

3.  Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?

Authors:  Holly Emms; Ioanna Tsirou; Treena Cranston; Stylianos Tsagarakis; Ashley B Grossman
Journal:  Endocrine       Date:  2016-06-15       Impact factor: 3.633

4.  ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

Authors:  Stéphanie Espiard; Ludivine Drougat; Rossella Libé; Guillaume Assié; Karine Perlemoine; Laurence Guignat; Gaelle Barrande; Françoise Brucker-Davis; Françoise Doullay; Stephanie Lopez; Emmanuel Sonnet; Florence Torremocha; Denis Pinsard; Nathalie Chabbert-Buffet; Marie-Laure Raffin-Sanson; Lionel Groussin; Françoise Borson-Chazot; Joël Coste; Xavier Bertagna; Constantine A Stratakis; Felix Beuschlein; Bruno Ragazzon; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2015-04-08       Impact factor: 5.958

Review 5.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 6.  Update on primary bilateral macronodular adrenal hyperplasia (PBMAH).

Authors:  Lucas Bouys; Iacopo Chiodini; Wiebke Arlt; Martin Reincke; Jérôme Bertherat
Journal:  Endocrine       Date:  2021-02-15       Impact factor: 3.633

7.  A case of severe hypertension caused by ACTH-independent macronodular adrenal hyperplasia.

Authors:  R Nocente; Marinis L De; A Mancini; A Bianchi; R Bellantone; L Lauriola; M Costanzo; Crea C De; G Gasbarrini; Silveri N Gentiloni
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

8.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Authors:  Guillaume Assié; Rossella Libé; Stéphanie Espiard; Marthe Rizk-Rabin; Anne Guimier; Windy Luscap; Olivia Barreau; Lucile Lefèvre; Mathilde Sibony; Laurence Guignat; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Franck Letourneur; Bilal Trabulsi; Alix Poussier; Nathalie Chabbert-Buffet; Françoise Borson-Chazot; Lionel Groussin; Xavier Bertagna; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

Review 9.  Surgery for Cushing's syndrome: an historical review and recent ten-year experience.

Authors:  John R Porterfield; Geoffrey B Thompson; William F Young; John T Chow; Raymond S Fryrear; Jon A van Heerden; David R Farley; John L D Atkinson; Fredric B Meyer; Charles F Abboud; Todd B Nippoldt; Neena Natt; Dana Erickson; Adrian Vella; Paul C Carpenter; Melanie Richards; J Aidan Carney; Dirk Larson; Cathy Schleck; Marilyn Churchward; Clive S Grant
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

10.  Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.

Authors:  Ulf Elbelt; Alessia Trovato; Michael Kloth; Enno Gentz; Reinhard Finke; Joachim Spranger; David Galas; Susanne Weber; Cristina Wolf; Katharina König; Wiebke Arlt; Reinhard Büttner; Patrick May; Bruno Allolio; Jochen G Schneider
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.